These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 29628309)
21. Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells. Sanders DA; Ross-Innes CS; Beraldi D; Carroll JS; Balasubramanian S Genome Biol; 2013 Jan; 14(1):R6. PubMed ID: 23347430 [TBL] [Abstract][Full Text] [Related]
22. Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer. Biswas A; Mukherjee G; Kondaiah P; Desai KV BMC Cancer; 2020 Nov; 20(1):1159. PubMed ID: 33246425 [TBL] [Abstract][Full Text] [Related]
23. Coactivator function defines the active estrogen receptor alpha cistrome. Lupien M; Eeckhoute J; Meyer CA; Krum SA; Rhodes DR; Liu XS; Brown M Mol Cell Biol; 2009 Jun; 29(12):3413-23. PubMed ID: 19364822 [TBL] [Abstract][Full Text] [Related]
24. Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells. Murakami S; Li R; Nagari A; Chae M; Camacho CV; Kraus WL Mol Cancer Res; 2019 Dec; 17(12):2356-2368. PubMed ID: 31551256 [TBL] [Abstract][Full Text] [Related]
25. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells. Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394 [TBL] [Abstract][Full Text] [Related]
26. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer. Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449 [TBL] [Abstract][Full Text] [Related]
27. NEAT1 repression by MED12 creates chemosensitivity in p53 wild-type breast cancer cells. Zhang S; Kim EJ; Huang J; Liu P; Donahue K; Wang Q; Wang Y; Mcilwain S; Xie L; Chen X; Li L; Xu W FEBS J; 2024 May; 291(9):1909-1924. PubMed ID: 38380720 [TBL] [Abstract][Full Text] [Related]
28. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer. Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393 [TBL] [Abstract][Full Text] [Related]
29. JMJD6 induces HOTAIR, an oncogenic lincRNA, by physically interacting with its proximal promoter. Biswas A; Shettar A; Mukherjee G; Kondaiah P; Desai KV Biochem J; 2018 Jan; 475(1):355-371. PubMed ID: 29229759 [TBL] [Abstract][Full Text] [Related]
30. Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation. Zhang X; Tanaka K; Yan J; Li J; Peng D; Jiang Y; Yang Z; Barton MC; Wen H; Shi X Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17284-9. PubMed ID: 24101509 [TBL] [Abstract][Full Text] [Related]
31. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT. Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941 [TBL] [Abstract][Full Text] [Related]
32. Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation. Li W; Hu Y; Oh S; Ma Q; Merkurjev D; Song X; Zhou X; Liu Z; Tanasa B; He X; Chen AY; Ohgi K; Zhang J; Liu W; Rosenfeld MG Mol Cell; 2015 Jul; 59(2):188-202. PubMed ID: 26166704 [TBL] [Abstract][Full Text] [Related]
34. USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α. Cao J; Wu D; Wu G; Wang Y; Ren T; Wang Y; Lv Y; Sun W; Wang J; Qian C; He L; Yang K; Li H; Gu H Cell Death Dis; 2021 Jun; 12(6):619. PubMed ID: 34131114 [TBL] [Abstract][Full Text] [Related]
35. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state. Kong SL; Li G; Loh SL; Sung WK; Liu ET Mol Syst Biol; 2011 Aug; 7():526. PubMed ID: 21878914 [TBL] [Abstract][Full Text] [Related]
36. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer. Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841 [TBL] [Abstract][Full Text] [Related]
37. Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription. Nagarajan S; Hossan T; Alawi M; Najafova Z; Indenbirken D; Bedi U; Taipaleenmäki H; Ben-Batalla I; Scheller M; Loges S; Knapp S; Hesse E; Chiang CM; Grundhoff A; Johnsen SA Cell Rep; 2014 Jul; 8(2):460-9. PubMed ID: 25017071 [TBL] [Abstract][Full Text] [Related]
38. Enhancer RNAs Mediate Estrogen-Induced Decommissioning of Selective Enhancers by Recruiting ERα and Its Cofactor. Yang M; Lee JH; Zhang Z; De La Rosa R; Bi M; Tan Y; Liao Y; Hong J; Du B; Wu Y; Scheirer J; Hong T; Li W; Fei T; Hsieh CL; Liu Z; Li W; Rosenfeld MG; Xu K Cell Rep; 2020 Jun; 31(12):107803. PubMed ID: 32579929 [TBL] [Abstract][Full Text] [Related]
39. Protein Arginine Methyltransferase CARM1 in Human Breast Cancer. Bacabac M; Liu P; Xu W Endocrinology; 2024 Jul; 165(8):. PubMed ID: 38878278 [TBL] [Abstract][Full Text] [Related]